Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1)

American Journal of Human Genetics

Volumn 61, Issue 1, 1997, Pages 80-87

  Mancini, Debora ^a,b   Singh, Shiva ^a,b   Ainsworth, Peter ^a,b   Rodenhiser, David ^a,b  

^a CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; BISULFITE; DINUCLEOTIDE; DNA;

ARTICLE; CLINICAL PROTOCOL; CODON; CONTROLLED STUDY; DEAMINATION; DNA METHYLATION; EXON; FIBROBLAST CULTURE; GENE DELETION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUMOR SUPPRESSOR GENE;

EID: 0030792795     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/513898     Document Type: Article

References (42)

1. Andrews JD, Mancini DN, Singh SM, Rodenhiser DI (1996) Site and sequence specific DNA methylation in the neurofibromatosis (NF1) gene includes C5839T: the site of the recurrent substitution mutation in exon 31. Hum Mol Genet 5:503-508
2. Antequera F, Boyes J, Bird A (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503-514
3. Barlow DP (1993) Methylation and imprinting: from host defense to gene regulation? Science 260:309-310
4. Bird AP (1987) CpG-rich islands and the function of DNA methylation. Trends Genet 3:342-347
5. Blanquet V, Turleau C, Gross-Morand MS, Senamaud-Beaufort C, Doz F, Besmond C (1995) Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 4:383-388
6. Canning S, Dryja TP (1989) Short direct repeats at the breakpoints of the retinoblastoma gene. Proc Natl Acad Sci USA 86:5044-5048
7. Clark SJ, Harrison J, Frommer M (1995) CpNpG methylation in mammalian cells. Nat Genet 10:20-27
8. Clark SJ, Harrison J, Paul CL, Frommer M (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22:2990-2997
9. Comb M, Goodman HM (1990) CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 18:3975-3982
10. Cooper DN, Krawczak M (1989) Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet 83:181-188
11. Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78:151-155
12. Cowell JK, Smith T, Bia B (1994) Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. Eur J Hum Genet 2:281-290
13. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, et al (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827-1831
14. Graessman M, Graessman A (1993) DNA methylation, chromatin structure and the regulation of gene expression. In: Jost JP, Saluz HP (eds) DNA methylation: molecular biology and biological significance. Birkhauser Verlag, Boston, pp 404-423
15. Greger V, Debus N, Lohmann D, Hopping W, Passarge E, Horsthemke B (1994) Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 94:491-496
16. Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83:155-158
17. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, et al (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36:714-721
18. Hogg A, Bia B, Onadim Z, Cowell JK (1993) Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. Proc Natl Acad Sci USA 90:7351-7355
19. Holler M, Westin G, Jiricny J, Schaffner W (1988) Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 2: 1127-1135
20. Iguchi-Ariga SMM, Schaffner W (1989) CpG methylation of the cAMP-responsive enhancer/promoter sequence TGA-CGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 3:612-619
21. Kato MV, Ishizaki K, Toguchida J, Kaneko A, Takayama J, Tanooka H, Kato T, et al (1994) Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patients with hereditary retinoblastoma. Hum Mutat 3:44-51
22. Keshet I, Lieman-Hurwitz J, Cedar H (1986) DNA methylation affects the formation of active chromatin. Cell 44:535-543
23. Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3:1487-1495
24. Leteurtre F, Kohlhagen G, Fesen MR, Tanizawa A, Kohn KW, Pommier Y (1994) Effects of DNA methylation on topoisomerase I and II cleavage activities. J Biol Chem 269: 7893-7900
25. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B (1994) Spectrum of small length germline mutations in the RB1 gene. Hum Mol Genet 3:2187-2193
26. _ (1996) The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 58:940-949
27. Magewu AN, Jones PA (1994) Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol 14:4225-4232
28. McArthur M, Thomas JO (1996) A preference of histone H1 for methylated DNA. EMBO J 15:1705-1714
29. Nan X, Tate P, Li E, Bird A (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 16:414-421
30. Ory K, Legros Y, Auguin C, Soussi T (1994) Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J 13:3496-3504
31. Pogribny IP, Poirier LA, James SJ (1995) Differential sensitivity to loss of cytosine methyl groups within the hepatic p53 gene of folate/methyl deficient rats. Carcinogenesis 16: 2863-2867
32. Razin A, Cedar H (1991) DNA methylation and gene expression. Microbiol Rev 55:451-458
33. Rodenhiser DI, Andrews JD, Mancini DN, Jung JH, Singh SM (1997) Homonucleotide tracts, short repeats and CpG/ CpNpG motifs are frequent sites for heterogeneous mutations in the neurofibromatosis type 1 (NF1) tumour-suppressor gene. Mutat Res 373:185-195
34. Rodenhiser DI, Chakraborty PK, Andrews JD, Ainsworth PJ, Mancini DN, Lopes E, Singh SM (1996) Heterogeneous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonucleotide tracts, short repeats and methylatable CpG/CpNpG motifs. Oncogene 12:2623-2629
35. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48: 880-888
36. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
37. Tasheva ES, Roufa DJ (1993) Deoxycytidine methylation and the origin of spontaneous transition mutations in mammalian cells. Somat Cell Mol Genet 19:275-283
38. Tate P, Skarnes W, Bird A (1996) The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet 12:205-208
39. Tornaletti S, Pfeifer GP (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene 10:1493-1499
40. Van Orsouw NJ, Li D, van der Vlies P, Scheffer H, Eng C, Buys C, Li FP, et al (1996) Mutational scanning of large genes by extensive PCR multiplexing and two-dimensional electrophoresis: application to the RB1 gene. Hum Mol Genet 5:755-761
41. Weng A, Engler P, Storb V (1995) Bulk chromatin structure of a murine transgene does not vary with its transcriptional or DNA methylation status. Mol Cell Biol 15:572-579
42. Zacksenhaus E, Bremner R, Phillips RA, Gallie BL (1993) A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol 13:4588-4599